查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032431

下一代糖尿病治療和藥物傳輸市場：按產品類型、人口統計、適應症、最終用戶和地區分類（2026-2034 年）

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic (Adult Population, Child Population ), Indication, End User (Diagnostic/Clinics, Intensive Care Units, Home Healthcare), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球新一代糖尿病治療和藥物傳輸市場規模達127億美元。展望未來，IMARC Group預測，該市場將從2026年到2034年以12.98%的複合年成長率成長，到2034年達到393億美元。糖尿病（尤其是第2型糖尿病）盛行率的上升、技術的不斷進步以及老年人口的成長是推動市場發展的主要因素。

新一代糖尿病治療和藥物傳遞技術著重於採用微創方式將胰島素輸送到患者體內，以降低頻繁使用針頭而引起的皮膚刺激風險。這種以患者為中心的治療方案旨在利用穿戴式感測器、微針和吸入式胰島素等創新技術，在有效控制病情的同時降低醫療成本。此外，持續血糖監測系統 (CGMS)、人工胰臟和胰島素貼片等先進治療方法也被用於改善血糖值控制並最大限度地降低糖尿病相關併發症的風險。這些方法還有助於劑量計算，實現血糖值的即時監測，並可實現無痛胰島素輸送，從而幫助患者堅持規律的給藥方案。這些治療方法和藥物傳遞方法的優點包括改善患者預後、提高治療效率以及減輕糖尿病患者的負擔，進而有助於制定更精準的治療方案。

下一代糖尿病治療和藥物傳輸市場的發展趨勢：

全球市場的主要驅動力是糖尿病（尤其是第2型糖尿病）在一般人群中日益成長的盛行率。這歸因於不健康的飲食習慣、久坐的生活方式和體力活動的減少。這導致人們對以患者為中心的個人化護理的需求不斷成長，這種護理能夠滿足個別需求、生活方式和治療目標，從而促進了產品的普及。此外，持續的技術進步，例如智慧胰島素筆、閉合迴路系統和副作用更少的植入式設備的開發，也在推動市場發展。同時，人們對微創和無痛治療方法日益成長的興趣也是市場成長的關鍵因素。醫療保健支出的成長和對基於價值的醫療解決方案的日益關注也進一步推動了市場發展。然而，對成本上升、認知不足以及發展中地區產品多樣性不足的擔憂是成長抑制因素的主要因素。另一方面，政府對醫療保健和早期療育的支持和報銷政策為市場創造了積極的前景。最後，老年人口的成長（老年人更容易罹患慢性病）也對市場產生了正面影響。其他推動市場發展的因素包括快速的都市化、人們對傳統糖尿病治療併發症的認知不斷提高、遠端醫療和數位健康解決方案的日益普及、可支配收入的增加以及主要公司開展的大量研發活動。

本報告解答的主要問題

  • 全球新一代糖尿病治療和藥物傳輸市場目前呈現出怎樣的態勢？未來幾年又有哪些發展趨勢？
  • 全球下一代糖尿病治療和藥物傳輸市場的促進因素、限制因素和機會是什麼？
  • 各種促進因素​​、阻礙因素和機會如何影響全球下一代糖尿病治療和藥物傳輸市場？
  • 主要區域市場有哪些？
  • 在全球下一代糖尿病治療和藥物傳輸市場中，哪個國家最具吸引力？
  • 以產品類型分類的市場結構是怎樣的？
  • 在全球新一代糖尿病治療和藥物傳輸市場中，哪種產品類型最具吸引力？
  • 依人口統計資料分類，市場組成是怎樣的？
  • 在全球下一代糖尿病治療和藥物傳輸市場中，哪個族群最具吸引力？
  • 按適應症分類的市場組成是什麼？
  • 在全球新一代糖尿病治療和藥物傳遞市場中，哪些適應症最具吸引力？
  • 依最終用戶分類的市場區隔如何？
  • 在全球新一代糖尿病治療和藥物傳輸市場中，哪些終端用戶最具吸引力？
  • 全球下一代糖尿病治療和藥物傳輸市場的競爭格局如何？
  • 全球下一代糖尿病治療和藥物輸送市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球下一代糖尿病治療與藥物傳遞市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 吸入式胰島素
  • 口服胰島素
  • 胰島素貼片
  • 動態血糖監測系統
  • 人工胰臟

第7章 市場區隔：依人口統計資料分類

  • 成年人口（14歲以上）
  • 兒童人口（14歲以下）

第8章 市場區隔：依適應症分類

  • 1型糖尿病
  • 2型糖尿病

第9章 市場區隔：依最終用戶分類

  • 診斷和臨床
  • 加護病房（ICU）
  • 家庭醫療保健

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Dexcom Inc.
    • Eli Lilly and Company
    • Enteris BioPharma Inc.（Swk Holdings Corporation）
    • GlySens Incorporated
    • MannKind Corporation
    • Medtronic plc
    • Sanofi
    • Senseonics
Product Code: SR112026A7519

The global next generation diabetes therapy and drug delivery market size reached USD 12.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 39.3 Billion by 2034, exhibiting a growth rate (CAGR) of 12.98% during 2026-2034. The rising prevalence of diabetes, particularly type-2 diabetes, continual technological advancements, and the growing geriatric population represent some of the key factors driving the market.

Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient's body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.

NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET TRENDS:

The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions. However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.

KEY MARKET SEGMENTATION:

Product Type Insights:

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

Demographic Insights:

  • Adult Population (>14 Years)
  • Child Population (14 Years)

Indication Insights:

  • Type 1 diabetes
  • Type 2 diabetes

End User Insights:

  • Diagnostic/Clinics
  • Intensive Care Units (ICUs)
  • Home Healthcare

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
  • What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
  • What are the key regional markets?
  • Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the demographic?
  • Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market?
  • What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
  • Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next Generation Diabetes Therapy and Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Inhalable Insulin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Oral Insulin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Insulin Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CGM Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Artificial Pancreas
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Demographic

  • 7.1 Adult Population (>14 Years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Child Population (14 Years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Type 1 Diabetes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type 2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Diagnostic/Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Intensive Care Units (ICUs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Healthcare
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Dexcom Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Eli Lilly and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlySens Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 MannKind Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Senseonics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials

List of Figures

  • Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2025
  • Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2025
  • Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2025
  • Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
  • Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million USD), 2026-2034
  • Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
  • Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players